Skip to main navigation
Skip to search
Skip to main content
Oregon Health & Science University Home
Help & FAQ
Home
Profiles
Research units
Core Facilities
Publications
Search by expertise, name or affiliation
Transplantation for CML: 2010
Richard T. Maziarz
Knight Cancer Institute
Research output
:
Contribution to journal
›
Comment/debate
›
peer-review
2
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Transplantation for CML: 2010'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Imatinib Mesylate
76%
Allogeneic Cells
72%
Stem Cell Transplantation
70%
Transplantation
51%
Safety
39%
Therapeutics
10%
Chemical Compounds
Imatinib
100%
Safety
57%